NADIA SAINA: Open Payments
NPI 1154783322 · BELLINGHAM, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$247 in 10 payments from 4 companies in 2025. Trend: 2023 $0 · 2024 $156 · 2025 $247
Food & beverage: $247
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $77 |
| Teva Pharmaceuticals USA, Inc. | 3 | $65 |
| ABBVIE INC. | 2 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $47 |
Products named: CAPLYTA, AUSTEDO XR, VRAYLAR, REXULTI.
Industry payments across WA — which companies pay providers there.
